Colitis Drug Hits 50% Remission Rate in Major Trial
A new pill for ulcerative colitis helped half of patients achieve complete remission in a groundbreaking trial, five times better than placebo. The results represent the best success rate ever reported for an oral medication treating this painful inflammatory bowel disease.